The first drug to treat macular telangiectasia type 2 (MacTel) – a neurodegenerative disease of the retina – has been approved by the United

GenTeal and In a Wink lubricant eye drops are no longer available via PBS subsidy (Pharmaceutical Benefits Scheme) in Australia.

Sydney-based ophthalmology practice Eye Associates is going all out to celebrate World Glaucoma Week, raising awareness about the "silent thief of sight" with a

A phase 3 study will evaluate the safety and efficacy of Ixo-vec (Adverum Biotechnologies), a one-time intravitreal (IVT) injection for patients with neovascular